The five-year relative survival rate for SEER stage “regional” is 65 percent. The five-year relative survival rate for SEER stage “distant” is 27 percent. Chondrosarcoma is a cancer that can begin in the bones or tissue near bones, often in the hip, pelvis, and shoulder. The five-year relative survival rate for SEER stage “regional” is 75 percent.

Survival rate for a young sarcoma patient can be varied anywhere from 5-10 years depending on the age of the patient and site of tumor. A 5 year survival rate for a child younger than 15 years is believed to be 76% and that of a 15-19 years aged child is 59%. Patients with localized tumours have 81% of 5 year survival rate and those with a diffused or metastatic tumours has 15% of 5 year survival rate.

Chondrosarcoma affects men and women equally, and typically appears in people between ages 40 and 75. The average age at diagnosis is 51. Is chondrosarcoma a common form of cancer? No, it’s not common. Approximately 600 people are diagnosed with chondrosarcoma each year. Are there different types of chondrosarcoma?

A chondrosarcoma is a rare, malignant (cancerous) bone tumor made up of cartilage cells, the firm tissue that protects the ends of bones. These bone sarcomas usually start in the pelvis, chest, arms, or legs. They can grow fairly large—often bigger than 4 centimeters across. Lower grade chondrosarcomas can grow very slowly over many years.